There is growing interest in the quality of health care delivery in liver transplantation. Multiple stakeholders, including patients, transplant providers and their hospitals, payers, and regulatory bodies have an interest in measuring and monitoring quality in the liver transplant process, and understanding differences in quality across centres. This article aims to provide an overview of quality measurement and regulatory issues in liver transplantation performed within the United States. We review how broader definitions of health care quality should be applied to liver transplant care models. We outline the status quo including the current regulatory agencies, public reporting mechanisms, and requirements around quality assurance and performance improvement (QAPI) activities. Additionally, we further discuss unintended consequences and opportunities for growth in quality measurement. Quality measurement and the integration of quality improvement strategies into liver transplant programmes hold significant promise, but multiple challenges to successful implementation must be addressed to optimise value.

中文翻译：

---

肝移植质量测量与改进

人们对肝移植中的医疗保健质量越来越感兴趣。包括患者、移植提供者及其医院、付款人和监管机构在内的多个利益相关者都对测量和监控肝脏移植过程的质量以及了解各中心之间的质量差异感兴趣。本文旨在概述在美国进行的肝移植的质量测量和监管问题。我们回顾了如何将更广泛的医疗保健质量定义应用于肝移植护理模型。我们概述了现状，包括当前的监管机构、公开报告机制以及围绕质量保证和绩效改进 (QAPI) 活动的要求。此外，我们进一步讨论了质量衡量方面的意外后果和增长机会。质量测量和将质量改进策略整合到肝移植计划中具有重要的前景，但必须解决成功实施的多重挑战以优化价值。